<DOC>
	<DOCNO>NCT02172924</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy use decidual stromal cell therapy graft versus host disease allogeneic hematopoietic stem cell transplantation . The hypothesis test cell safe infuse positive clinical effect .</brief_summary>
	<brief_title>A Phase 2 Study Using Placenta Derived Decidual Stromal Cells Graft Versus Host Disease</brief_title>
	<detailed_description>Patients GVHD grade 2-4 , receive decidual stromal cell approximately 1x10^6 cells/kg one occasion weekly interval dependent clinical response .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Acute graft versus host disease grade 24 therapy resistant chronic graft versus host disease . Are calcineurin inhibitor high dose corticosteroid . Terminally ill patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Stem Cell Transplantation</keyword>
	<keyword>Decidual Stromal Cells</keyword>
</DOC>